期刊文献+

大于40岁ALT正常慢性HBV感染者肝组织纤维化分期的研究 被引量:2

Liver fibrosis of chronic HBV infected patients older than 40-year-old with normal ALT.
下载PDF
导出
摘要 目的观察大于40岁ALT正常慢性HBV感染者的肝组织纤维化分期的情况。方法选择64例慢性HBV感染者,检测血清肝功能、HBeAg、HBVDNA、进行肝脏活检,提供肝组织纤维化分期情况。结果年龄大于40岁ALT正常慢性HBV感染者肝组织73.44%有2期及以上的纤维化。肝纤维分期与Ⅲ型前胶原、透明质酸具有相关性(P<0.05),HBVDNA、HBeAg与肝组织纤维化无相关性(P>0.05)。结论大于40岁ALT正常的HBV慢性感染者有3/4肝组织纤维分期在2期以上,应关注其抗纤维化治疗。 Objective To analyze the stages of liver fibrosis in patients aged older than 40 with normal ALT. Methods 84 patients with chronic HBV infected were investigated in this study. Liver function, HBeAg, HBVDNA, serum liver fibrosis indexes were tested. And liver biopsy was taken in all the patients and the tissues were stained with HE and Masson. Results 73.4% patients were at fibrosis stage 2 - 4. The serum fibrosis indexes correlated with the fibrosis stage of liver histology. While the levels of HBeAg and HBVDNA didnt correlate with the severity of liver fibrosis. Conclusion Liver fibrosis of patients older than 40 - year - old should be analyzed synthetically with many clinical indexes. These patients should be administered with antifibrosis therapy to prevent the progression of liver cirrhosis.
作者 李静
出处 《临床肝胆病杂志》 CAS 2009年第3期182-183,共2页 Journal of Clinical Hepatology
关键词 HBVDNA ALT HBEAG 肝组织病理 HBVDNA ALT HBeAg hepatic histopathology
  • 相关文献

参考文献10

  • 1中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 2Pratt DS, Kalplan MM. Evaluatinon of abnormal liver- enzymeresuhs in asymptomatic patients[ J]. N Engl J Med,2000,342( 17 ): 1266 - 1271.
  • 3Craxi A, Ahnasio P. Diagnostic approach to liver enzyme elevation [ J ]. Hepatol, 1996, 25 (Suppl) : S47 - S51.
  • 4Wang C, Deubner H, Shuhart M, et al. High prevalence of significant fibrosis in patients with immunotolerance to chronic hepatitis B infection [ J ]. Hepatology,2005,42 ( Suppl 1 ) : 537 A.
  • 5宋鸿硕,石爽,庄辉.ALT水平正常的慢性乙型肝炎研究进展[J].传染病信息,2007,20(1):7-8. 被引量:17
  • 6Keeffe EB, Dieterich DT, Han SH, et al Treatment algorithm for the management of chronic hepatitis B virus infection in the United States [ J ]. Clin Gastroenterol Hepatol,2004,2 ( 2 ) : 87 - 106.
  • 7Keeffe EB, Dieterich DT, Han SH, et ah Treatent algorithm for the management of chronic hepatitis B virus infection in the United States: an update [ J]. Clin Gastroenterol Hepatol, 2006,4 ( 8 ) : 936 - 962.
  • 8Chu CM,Hung SJ,Lin J, et al. Natural history of hepatitis B e antigen to antibody seroconversion in patients with nomal serum aminotransferase levels [ J]. Am J Med, 2004,116 (12) : 829 834.
  • 9Brunetto MR, Oliveri F, Coco B,. Outcome of anti - HBe positive chronic hepatitis B in alpha- interferon treated and untreated patients : a long term cohort study [ J ]. Hepatol, 2002,36:263 - 270.
  • 10王建军,成军.乙型肝炎病毒e抗原的生物学作用[J].胃肠病学和肝病学杂志,2004,13(1):76-78. 被引量:11

二级参考文献32

  • 1骆抗先,主编.乙型肝炎基础和临床.第2版.北京:人民卫生出版社,2001.49-50.
  • 2Dieye A, Obami-Ttou V, Barry MF, et al. Association between Class IHLA allles and HBs antigen carrier status among blood donors in Senegal. Dakar Med, 1999,44(2) : 166-170.
  • 3Barth H, Klein R, Berg PA, et al. Tnduction of T helper cell type 1 response and elimination of HBeAg during treatment with TL-12 in a patient with therapy-refractory chronic hepatitis B. HepatogastroenteroLogY, 2001,48 (38) : 553-555.
  • 4Merkle H, Deutschle T, Gastrock-Balitsch T, et al. H-2(d) mice born to and reared by HBeAg-transgenic mothers do not develop T cell tolerance toward the hepatitis B virus core gene products. Virology, 2000, 273 ( 1 ) :149-159.
  • 5Khakoo SI, Ling R, Scott l, et al. Cytotoxic T lymphocyte resDonses and CTL epitope escape mutation in HBsAg, anti-HBe positi. ve individuals.Gut, 2000,47(1) : 137-143.
  • 6Zavaglia C, Severini R, Tinelli C, et al. A randomized, controlled study of thymosin-alphal therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B. Dig Dis Sci, 2000, 45(4) :690-696.
  • 7Krastev Z, Jelev D, Antonov K, et al. Chronic HBV infection. Tmmunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients-a pilot study. Hepatogastroenterology, 1999, 46(30) : 3184-3188.
  • 8Papatheodoridis GV, Hadziyannis SJ. Diagnosis and management of precore mutant chronic hepatitis B. J Viral Hepat, 2001, 8(5) :311-321.
  • 9Dong J, Cheng J, Wang Q, et al. The study on heterogeneity of hepatitis B virus DNA. Zhonghua Yi Xue Za Zhi, 2002, 82(2) :81-85.
  • 10Scaglioni PP, Melegari M, Wands JR. Posttranscrlptional regulation of hepatitis B virus repl' ication by the precore protein. J Virol, 1997,71(1) :345-353.

共引文献14023

同被引文献22

  • 1张新元,宁更献,彭霞,侯军良,王惠芳.慢性HBV携带者肝脏病理改变及其临床意义[J].河北医药,2007,29(1):65-65. 被引量:10
  • 2李嘉,赵桂鸣,朱理珉,李颖,辛绍杰.免疫耐受期和非活动复制期乙型肝炎病毒感染者的肝脏病理与临床特征[J].中华肝脏病杂志,2007,15(5):326-329. 被引量:39
  • 3李知玉,吴其恺,何清,等.慢性HBV感染者血清HBeAg及HBVDNA与肝组织病理分级分期的关系[C].中华中医药学会全国第十四次肝胆病学术会议论文汇编,2010:477-481.
  • 4Wang C, Deubner H, Shuhart M, et al. High prevalence of significant fibrosis in patients with immun0tolerance to chronic hepatitis B infection (abstr)[J]. Hepatology,2005,42: 573A.
  • 5Kim HC, Nam CM, Jee SH, et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study[J]. BMJ,2004,328:983.
  • 6Kariv R, Leshno M, Beth-Or A, et al. Re-evaluation of serum alanine aminotransferase upper normal limit and its modulating factors in a large-scale population study[J]. Liver Int,2006,26:445-450.
  • 7Hui CK, Leung N, Yuen ST, et al. Natural history and disease progression in Chinese chronic hepatitis B patients in immune- tolerant phase[J]. Hepatology,2007,46:395-401.
  • 8Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update[J]. Clin Gastroenterol Hepatol,2006,4:936-962.
  • 9Hsu HC, Su IJ, Lai MY, et al. Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus infection[J]. Journal of hepatology, 1987,5:45 -50.
  • 10Chu CM, Yeh CT, Sheen IS, et al. Subcellular localization of hepatitis B core antigen in relation to hepatocyte regeneration in chronic hepatitis B [J]. Gastroenterology, 1995,109:1926-1932.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部